Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Profit Warning 28.01.2014 19:11 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Berlin, January 28, 2014. Today's meeting of the Supervisory Board of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) discussed the preliminary results for fiscal year 2013. Despite previous expectations of a strong fourth quarter of 2013, initial analysis has revealed only slightly above-average performance. As a result, a year-on-year drop in net income for the year of 15% to 20% (EUR 1.95 per share) is anticipated for fiscal year 2013. This also changes the basis of the forecast for 2014, which is, however, still following the pattern of long-term growth. All figures are provisional and are subject to an audit and the approval of the financial statements by the Supervisory Board. The audited results will be published along with the annual financial statements on March 27, 2014. If you have any questions, please contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.de 28.01.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Eckert & Ziegler Strahlen- und Medizintechnik AG Robert-Rössle-Str.10 13125 Berlin Germany Phone: 49 30 941084-138 Fax: 49 30 941084-112 E-mail: [email protected] Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, Düsseldorf, Hamburg, München End of Announcement DGAP News-Service ---------------------------------------------------------------------------